Dioxaphetyl butyrate
| Dioxaphetyl butyrate | |
|---|---|
| Spasmoxal.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Dioxaphetyl butyrate is a synthetic opioid analgesic that was developed in the mid-20th century. It is known for its potent analgesic properties and is used in the management of moderate to severe pain.
Chemical Structure[edit]
Dioxaphetyl butyrate is chemically classified as an opioid, which means it is a compound that binds to opioid receptors in the central nervous system. The chemical structure of Dioxaphetyl butyrate includes a phenyl group and a butyrate ester, which contribute to its pharmacological activity.
Pharmacology[edit]
Dioxaphetyl butyrate acts primarily as an agonist at the mu-opioid receptor, which is responsible for its analgesic effects. By binding to these receptors, it inhibits the transmission of pain signals in the nervous system. This mechanism is similar to that of other opioids, such as morphine and fentanyl.
Medical Uses[edit]
Dioxaphetyl butyrate is used in the treatment of moderate to severe pain, particularly in cases where other analgesics are ineffective. It is important to note that, like other opioids, it has the potential for abuse and dependence, and its use is typically restricted to situations where alternative treatments are not suitable.
Side Effects[edit]
Common side effects of Dioxaphetyl butyrate include nausea, vomiting, constipation, and drowsiness. More serious side effects can include respiratory depression, which is a potentially life-threatening condition where breathing becomes inadequate.
Regulation[edit]
Due to its potential for abuse, Dioxaphetyl butyrate is classified as a controlled substance in many countries. Its distribution and use are strictly regulated to prevent misuse and addiction.
